PortfoliosLab logoPortfoliosLab logo
RHHBY vs. MDT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RHHBY vs. MDT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Roche Holding AG (RHHBY) and Medtronic plc (MDT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RHHBY achieves a 1.04% return, which is significantly higher than MDT's -15.31% return. Over the past 10 years, RHHBY has outperformed MDT with an annualized return of 7.66%, while MDT has yielded a comparatively lower 2.04% annualized return.


RHHBY

1D
-1.81%
1M
-1.06%
YTD
1.04%
6M
6.55%
1Y
27.52%
3Y*
12.73%
5Y*
4.71%
10Y*
7.66%

MDT

1D
-1.20%
1M
5.96%
YTD
-15.31%
6M
-19.07%
1Y
-4.79%
3Y*
2.04%
5Y*
-5.25%
10Y*
2.04%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RHHBY vs. MDT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
RHHBY
Roche Holding AG
1.04%52.86%0.23%-4.02%-22.21%20.20%9.94%33.47%2.16%14.32%
MDT
Medtronic plc
-15.31%24.05%0.28%9.58%-22.55%-9.79%5.70%27.34%15.18%15.90%

Correlation

The correlation between RHHBY and MDT is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (10Y)
Calculated over the trailing 10-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Jan 3, 2001

0.26

Fundamentals

EPS

RHHBY:

$5.42

MDT:

$3.58

PE Ratio

RHHBY:

9.33

MDT:

22.52

PS Ratio

RHHBY:

1.51

MDT:

2.93

Total Revenue (TTM)

RHHBY:

$107.65B

MDT:

$35.48B

Gross Profit (TTM)

RHHBY:

$79.28B

MDT:

$5.78B

EBITDA (TTM)

RHHBY:

$31.01B

MDT:

$7.11B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RHHBY vs. MDT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RHHBY
RHHBY Risk / Return Rank: 7070
Overall Rank
RHHBY Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
RHHBY Sortino Ratio Rank: 6969
Sortino Ratio Rank
RHHBY Omega Ratio Rank: 6767
Omega Ratio Rank
RHHBY Calmar Ratio Rank: 6969
Calmar Ratio Rank
RHHBY Martin Ratio Rank: 7070
Martin Ratio Rank

MDT
MDT Risk / Return Rank: 3131
Overall Rank
MDT Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
MDT Sortino Ratio Rank: 2727
Sortino Ratio Rank
MDT Omega Ratio Rank: 2727
Omega Ratio Rank
MDT Calmar Ratio Rank: 3737
Calmar Ratio Rank
MDT Martin Ratio Rank: 3434
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RHHBY vs. MDT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Roche Holding AG (RHHBY) and Medtronic plc (MDT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RHHBYMDTDifference
Sharpe ratioReturn per unit of total volatility

+1.24

Sortino ratioReturn per unit of downside risk

+1.86

Omega ratioGain probability vs. loss probability

1.20

0.98

+0.22

Calmar ratioReturn relative to maximum drawdown

1.43

-0.17

+1.59

Martin ratioReturn relative to average drawdown

3.49

-0.43

+3.92

RHHBY vs. MDT - Sharpe Ratio Comparison

The current RHHBY Sharpe Ratio is 1.01, which is higher than the MDT Sharpe Ratio of -0.23. The chart below compares the historical Sharpe Ratios of RHHBY and MDT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


RHHBYMDTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.01

-0.23

+1.24

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.20

-0.24

+0.44

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.34

0.09

+0.25

Sharpe Ratio (All Time)

Calculated using the full available price history

0.35

0.47

-0.12

Drawdowns

RHHBY vs. MDT - Drawdown Comparison

The maximum RHHBY drawdown since its inception was -45.73%, smaller than the maximum MDT drawdown of -57.63%. Use the drawdown chart below to compare losses from any high point for RHHBY and MDT.


Loading charts...

Drawdown Indicators


RHHBYMDTDifference

Max Drawdown

Largest peak-to-trough decline

-45.73%

-57.63%

+11.90%

Max Drawdown (1Y)

Largest decline over 1 year

-19.38%

-28.90%

+9.52%

Max Drawdown (3Y)

Largest decline over 3 years

-23.46%

-28.90%

+5.44%

Max Drawdown (5Y)

Largest decline over 5 years

-40.88%

-45.10%

+4.22%

Max Drawdown (10Y)

Largest decline over 10 years

-40.88%

-45.10%

+4.22%

Current Drawdown

Current decline from peak

-13.99%

-30.81%

+16.82%

Average Drawdown

Average peak-to-trough decline

-12.84%

-16.54%

+3.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.91%

11.17%

-3.26%

Volatility

RHHBY vs. MDT - Volatility Comparison

The current volatility for Roche Holding AG (RHHBY) is 8.10%, while Medtronic plc (MDT) has a volatility of 10.04%. This indicates that RHHBY experiences smaller price fluctuations and is considered to be less risky than MDT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RHHBYMDTDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.10%

10.04%

-1.94%

Volatility (6M)

Calculated over the trailing 6-month period

18.55%

16.19%

+2.36%

Volatility (1Y)

Calculated over the trailing 1-year period

27.48%

20.95%

+6.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.39%

21.93%

+1.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.58%

23.24%

-0.66%

Dividends

RHHBY vs. MDT - Dividend Comparison

RHHBY's dividend yield for the trailing twelve months is around 3.07%, less than MDT's 3.52% yield.


PositionTTM20252024202320222021202020192018201720162015
MDT
Medtronic plc
3.52%2.95%3.49%3.34%3.44%2.39%1.95%1.87%2.15%2.24%2.34%1.88%
RHHBY
Roche Holding AG
3.07%2.69%3.87%3.55%3.23%1.57%1.66%1.70%3.58%3.25%3.57%2.91%

Financials

RHHBY vs. MDT - Financials Comparison

This section allows you to compare key financial metrics between Roche Holding AG and Medtronic plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B15.00B20.00B25.00B30.00B202120222023202420252026
30.32B
9.02B
(RHHBY) Total Revenue
(MDT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


RHHBY and MDT have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MDT has higher volatility (10.04%) compared to RHHBY (8.10%). In terms of maximum drawdown, RHHBY dropped -45.73% vs MDT's -57.63%.

RHHBY currently has the higher Sharpe Ratio (1.01 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RHHBY and MDT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer